Lyric Pharmaceuticals Overview

  • Founded
  • 2013
Founded
  • Status
  • Out of Business
  • Employees
  • 7
Employees
  • Latest Deal Type
  • Out of Business

Lyric Pharmaceuticals General Information

Description

Developer of gastrointestinal therapeutics designed to treat gastrointestinal infections. The company's therapeutics include pro-kinetic and pro-metabolic drugs for unmet medical needs, enabling patients to access treatment of enteral feeding intolerance in the intensive care unit.

Contact Information

Ownership Status
Out of Business
Financing Status
Formerly VC-backed
Primary Industry
Drug Discovery
Other Industries
Pharmaceuticals
Biotechnology
Primary Office
  • 601 Gateway Boulevard
  • Suite 1020
  • South San Francisco, CA 94080
  • United States
Want detailed data on 2M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Lyric Pharmaceuticals Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Out of Business 01-Jul-2019 000.00 Completed Out of Business
2. Early Stage VC (Series A) 21-Apr-2017 000.00 000.00 0000 Completed Clinical Trials - Phase 2
1. Seed Round 01-Jan-2014 $825K $825K Completed Clinical Trials - Phase 2
To view Lyric Pharmaceuticals’s complete valuation and funding history, request access »

Lyric Pharmaceuticals Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series A2 00,000,000 00.000000 00 00.00 00.00 00 00.00 00.000
Series A1 0,000,000 00.000000 00 00.00 00.00 00 00.00 00.000
To view Lyric Pharmaceuticals’s complete cap table history, request access »

Lyric Pharmaceuticals Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Developer of gastrointestinal therapeutics designed to treat gastrointestinal infections. The company's therapeutics inc
Drug Discovery
South San Francisco, CA
7 As of 2016
000.00
00000000 00 000.00

00000000

quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure d
0000 000000000
New York, NY
000 As of 0000
00000
000000 - 000 00000

000 0000

d do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostr
0000 000000000
Princeton, NJ
0000
0000 0000-00-00
00000000000 0000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Lyric Pharmaceuticals Competitors (42)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Intercept(Biotechnology) Formerly VC-backed New York, NY 000 00000 000000 - 000 00000
000 00000000000 Venture Capital-Backed Princeton, NJ 0000 00000000000 0000
0000000 Venture Capital-Backed Cambridge, MA 00 00000 00000000 00000
0000000 Venture Capital-Backed Lelystad, Netherlands 00 0000 000000 - 000 0000
000000000 Formerly VC-backed South San Francisco, CA 00000 000.00 00000000000
You’re viewing 5 of 42 competitors. Get the full list »

Lyric Pharmaceuticals Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial